Skip to content
Governance Register

← US public companies

Icosavax, Inc.

SEC CIK 1786255 · ICVX · last insider filing 2024-02-20

Directors (from insider filings)

NameCapacity as filedFilings
Kunz Heidi Director filed 2021 - 2024
Mcdade Mark Director filed 2021 - 2024
RA Capital Healthcare Fund LP Director filed 2021 - 2024
RA Capital Management, LLC Director filed 2021 - 2024
Kolchinsky Peter Director filed 2021 - 2024
Veneman Ann M Director filed 2021 - 2024
Shah Rajeev M. Director filed 2021 - 2024
Wassil Jim Director filed 2022 - 2024
RA Capital Nexus Fund II, L.P. Director filed 2021 - 2024
Simpson Adam K. Director · Chief Executive Officer filed 2021 - 2024
Shiver John W. Director filed 2022 - 2024
RA Capital Nexus Fund, L.P. Director filed 2023 - 2023
Gould Terry P Director filed 2021 - 2021
Qiming U.S. Healthcare Fund II, L.P. Director filed 2021 - 2021
Yamada Tadataka Director filed 2021 - 2021

Officers (from insider filings)

NameTitle as filedFilings
Russo Thomas Joseph Chief Financial Officer filed 2021 - 2024
Cearley Cassia Chief Business Officer filed 2021 - 2024
Kanesa-Thasan Niranjan Chief Medical Officer filed 2021 - 2024
Khan Amin EVP, Head of Research & Dev. filed 2023 - 2024
Holtzman Douglas Chief Scientific Officer filed 2021 - 2023
Bekiroglu Elizabeth See Remarks filed 2021 - 2023
Richardson Charles E See Remarks filed 2021 - 2022

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.